Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Antimicrob Agents Chemother ; 43(10): 2389-94, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10508012

RESUMEN

The effect of antibiotics on the acute lung injury induced by virulent Pseudomonas aeruginosa PA103 was quantitatively analyzed in a rat model. Lung injury was induced by the instillation of PA103 directly into the right lower lobes of the lungs of anesthetized rats. The alveolar epithelial injury, extravascular lung water, and total plasma equivalents were measured as separate, independent parameters of acute lung injury. Four hours after the instillation of PA103, all the parameters were increased linearly depending on the dose of P. aeruginosa. Next, we examined the effects of intravenously administered antibiotics on the parameters of acute lung injury in D-galactosamine-sensitized rats. One hour after the rats received 10(7) CFU of PA103, an intravenous bolus injection of aztreonam (60 mg/kg) or imipenem-cilastatin (30 mg/kg) was administered. Despite an MIC indicating resistance, imipenem-cilastatin improved all the measurements of lung injury; in contrast, aztreonam, which had an MIC indicating sensitivity, did not improve any of the lung injury parameters. The antibiotics did not generate different quantities of plasma endotoxin; therefore, endotoxin did not appear to explain the differences in lung injury. This in vivo model is useful to quantitatively compare the efficacies of parenteral antibiotic administration on Pseudomonas airspace infections.


Asunto(s)
Quimioterapia Combinada/uso terapéutico , Enfermedades Pulmonares/patología , Infecciones por Pseudomonas/tratamiento farmacológico , Pseudomonas aeruginosa/efectos de los fármacos , Animales , Aztreonam/farmacología , Aztreonam/uso terapéutico , Cilastatina/farmacología , Cilastatina/uso terapéutico , Combinación Cilastatina e Imipenem , Modelos Animales de Enfermedad , Combinación de Medicamentos , Quimioterapia Combinada/farmacología , Imipenem/farmacología , Imipenem/uso terapéutico , Enfermedades Pulmonares/microbiología , Masculino , Pruebas de Sensibilidad Microbiana , Monobactamas/farmacología , Monobactamas/uso terapéutico , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/patogenicidad , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA